On October 23, Kimberly-Clark rose 5.24% in Regular Trading, trading at $112.235 per share, with turnover of $403 million.
The clearest catalyst was the company’s pricing of a $4.9 billion senior unsecured notes offering, which the market viewed as a concrete financing step supporting its proposed Kenvue acquisition and increasing confidence that the transaction will close.
The debt sale was structured in five tranches maturing from 2028 to 2036, with coupons ranging from 5.10% to 5.80%, and is expected to settle on October 29. The company said proceeds, together with cash on hand, will fund the acquisition and related costs. If the deal is abandoned or does not close within the specified period, the notes may need to be redeemed at 101% of principal plus accrued interest.
The financing progress follows conditional European approval for the roughly $40 billion transaction, with Kimberly-Clark agreeing to divest certain feminine care brands in the European Economic Area. Recent support also included management preparations for the combined company and reiterated annual guidance despite softer sales trends.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments